Restart Life Sciences Corp. (CSE:HEAL)
Canada · Delayed Price · Currency is CAD 0.0750
0.00 (0.00%)
Sep 18, 2026, 9:22 AM EST
Restart Life Sciences Revenue
Restart Life Sciences had revenue of 331.16K CAD in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 465.72K.
Revenue (ttm)
465.72K
Revenue Growth
n/a
P/S Ratio
10.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Restart Life Sciences News
- 4 days ago - Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience - Newsfile Corp
- 16 days ago - Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth - Newsfile Corp
- 18 days ago - Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations - Newsfile Corp
- 5 weeks ago - Restart Life Sciences Announces Production Launch of New Holy Crap Protein Line - Newsfile Corp
- 7 weeks ago - Restart Life Sciences Announces Strategic Focus on Targeted M&A Expansion in Health and CPG Sectors - Newsfile Corp
- 2 months ago - Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods - Newsfile Corp
- 2 months ago - Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks - Newsfile Corp
- 2 months ago - Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap - Newsfile Corp